News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CSPC PHARMA (01093.HK) In-house SYS 6010 Included Again in China Breakthrough Therapy Designation List
CSPC PHARMA (01093.HK) announced that its self-developed SYS 6010 (an EGFR-targeting humanized monoclonal antibody-drug conjugate) has recently been included again by the National ...
Reset
Send
The window will close in 5 seconds
CSPC PHARMA (01093.HK) In-house SYS 6010 Included Again in China Breakthrough Therapy Designation List
Close
Recommend
8
Positive
13
Negative
4
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!

CSPC PHARMA (01093.HK)  -0.060 (-0.740%)    Short selling $90.59M; Ratio 14.677%   announced that its self-developed SYS 6010 (an EGFR-targeting humanized monoclonal antibody-drug conjugate) has recently been included again by the National Medical Products Administration in the Breakthrough Therapy Designation list.
The proposed indication is monotherapy for patients with locally advanced or metastatic esophageal squamous cell carcinoma who have previously failed platinum-containing chemotherapy and immunotherapy. (sl/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)

Related NewsCiti: Fundamentals of China Healthcare Sector Continue to Improve; Top Picks WUXI APPTEC (02359.HK), WUXI BIO (02269.HK), ALI HEALTH (00241.HK)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.